Cynosure Lutronic has announced CE Mark approval under the European Medical Device Regulation (MDR) for its Mosaic 3D fractional resurfacing platform.

This development supports the company’s strategy for international expansion of its advanced non-ablative fractional laser technology.

The Mosaic 3D device incorporates several features designed to enhance safety and patient comfort. Its 3D controlled chaos technology (CCT) optimises the multi-depth microbeams distribution and depth, helping minimise the risk of bulk thermal heating while increasing treatment coagulation volume per stamp without compromising safety.